A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced Tumours
Clinical trial NCT05607563 · UNKNOWN
Trial details
- NCT number
- NCT05607563
- Sponsor
- Biotheus Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-21
- Primary completion
- 2023-11-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.